These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
356 related items for PubMed ID: 10868966
1. Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Nakagawa T, Tsuchida A, Itakura Y, Nonomura T, Ono M, Hirota F, Inoue T, Nakayama C, Taiji M, Noguchi H. Diabetes; 2000 Mar; 49(3):436-44. PubMed ID: 10868966 [Abstract] [Full Text] [Related]
2. Protective effect of brain-derived neurotrophic factor on pancreatic islets in obese diabetic mice. Yamanaka M, Itakura Y, Inoue T, Tsuchida A, Nakagawa T, Noguchi H, Taiji M. Metabolism; 2006 Oct; 55(10):1286-92. PubMed ID: 16979397 [Abstract] [Full Text] [Related]
4. Intermittent administration of brain-derived neurotrophic factor (BDNF) ameliorates glucose metabolism and prevents pancreatic exhaustion in diabetic mice. Yamanaka M, Itakura Y, Ono-Kishino M, Tsuchida A, Nakagawa T, Taiji M. J Biosci Bioeng; 2008 Apr; 105(4):395-402. PubMed ID: 18499057 [Abstract] [Full Text] [Related]
5. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice. Yamanaka M, Itakura Y, Tsuchida A, Nakagawa T, Noguchi H, Taiji M. Diabetes Obes Metab; 2007 Nov; 9(6):879-88. PubMed ID: 17924870 [Abstract] [Full Text] [Related]
6. Brain-derived neurotrophic factor ameliorates lipid metabolism in diabetic mice. Tsuchida A, Nonomura T, Nakagawa T, Itakura Y, Ono-Kishino M, Yamanaka M, Sugaru E, Taiji M, Noguchi H. Diabetes Obes Metab; 2002 Jul; 4(4):262-9. PubMed ID: 12099975 [Abstract] [Full Text] [Related]
7. Acute effects of brain-derived neurotrophic factor on energy expenditure in obese diabetic mice. Tsuchida A, Nonomura T, Ono-Kishino M, Nakagawa T, Taiji M, Noguchi H. Int J Obes Relat Metab Disord; 2001 Sep; 25(9):1286-93. PubMed ID: 11571589 [Abstract] [Full Text] [Related]
8. Brain-derived neurotrophic factor (BDNF) regulates glucose and energy metabolism in diabetic mice. Nakagawa T, Ono-Kishino M, Sugaru E, Yamanaka M, Taiji M, Noguchi H. Diabetes Metab Res Rev; 2002 Sep; 18(3):185-91. PubMed ID: 12112936 [Abstract] [Full Text] [Related]
9. Anti-obesity and anti-diabetic effects of brain-derived neurotrophic factor in rodent models of leptin resistance. Nakagawa T, Ogawa Y, Ebihara K, Yamanaka M, Tsuchida A, Taiji M, Noguchi H, Nakao K. Int J Obes Relat Metab Disord; 2003 May; 27(5):557-65. PubMed ID: 12704399 [Abstract] [Full Text] [Related]
10. The effects of brain-derived neurotrophic factor on insulin signal transduction in the liver of diabetic mice. Tsuchida A, Nakagawa T, Itakura Y, Ichihara J, Ogawa W, Kasuga M, Taiji M, Noguchi H. Diabetologia; 2001 May; 44(5):555-66. PubMed ID: 11380073 [Abstract] [Full Text] [Related]
11. Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice. Tonra JR, Ono M, Liu X, Garcia K, Jackson C, Yancopoulos GD, Wiegand SJ, Wong V. Diabetes; 1999 Mar; 48(3):588-94. PubMed ID: 10078561 [Abstract] [Full Text] [Related]
13. Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice. Fujiwara T, Wada M, Fukuda K, Fukami M, Yoshioka S, Yoshioka T, Horikoshi H. Metabolism; 1991 Nov; 40(11):1213-8. PubMed ID: 1943750 [Abstract] [Full Text] [Related]
14. Brain-derived neurotrophic factor enhances glucose utilization in peripheral tissues of diabetic mice. Yamanaka M, Tsuchida A, Nakagawa T, Nonomura T, Ono-Kishino M, Sugaru E, Noguchi H, Taiji M. Diabetes Obes Metab; 2007 Jan; 9(1):59-64. PubMed ID: 17199719 [Abstract] [Full Text] [Related]
15. Intermittent administration of brain-derived neurotrophic factor ameliorates glucose metabolism in obese diabetic mice. Ono M, Itakura Y, Nonomura T, Nakagawa T, Nakayama C, Taiji M, Noguchi H. Metabolism; 2000 Jan; 49(1):129-33. PubMed ID: 10647076 [Abstract] [Full Text] [Related]
16. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats. Chang AY, Wyse BM, Gilchrist BJ, Peterson T, Diani AR. Diabetes; 1983 Sep; 32(9):830-8. PubMed ID: 6354790 [Abstract] [Full Text] [Related]
17. Brain-derived neurotrophic factor reduces blood glucose level in obese diabetic mice but not in normal mice. Ono M, Ichihara J, Nonomura T, Itakura Y, Taiji M, Nakayama C, Noguchi H. Biochem Biophys Res Commun; 1997 Sep 18; 238(2):633-7. PubMed ID: 9299565 [Abstract] [Full Text] [Related]
18. Topiramate ameliorates hyperglycaemia and improves glucose-stimulated insulin release in ZDF rats and db/db mice. Liang Y, Chen X, Osborne M, DeCarlo SO, Jetton TL, Demarest K. Diabetes Obes Metab; 2005 Jul 18; 7(4):360-9. PubMed ID: 15955122 [Abstract] [Full Text] [Related]
19. Pioglitazone improves insulin secretory capacity and prevents the loss of beta-cell mass in obese diabetic db/db mice: Possible protection of beta cells from oxidative stress. Ishida H, Takizawa M, Ozawa S, Nakamichi Y, Yamaguchi S, Katsuta H, Tanaka T, Maruyama M, Katahira H, Yoshimoto K, Itagaki E, Nagamatsu S. Metabolism; 2004 Apr 18; 53(4):488-94. PubMed ID: 15045697 [Abstract] [Full Text] [Related]
20. Brain-derived neurotrophic factor bound with lecithin derivative showed a markedly enhanced pharmacological potency due to its potent cell membrane affinity followed by prolonged MAPK activation. Igarashi R, Nakayama T, Takenaga M, Ichinohe M, Yamaguchi Y, Matsumoto K, Kitagawa A, Nakamura N, Kawai S, Nakagawa T, Taiji M, Nakayama C, Mizushima Y. J Control Release; 2005 Feb 02; 102(2):463-73. PubMed ID: 15653164 [Abstract] [Full Text] [Related] Page: [Next] [New Search]